What is NDC 59651-515?

59651-515 is the product NDC for Aripiprazole, Aripiprazole 15 mg/1 tablet, orally disintegrating, listed with the FDA by Aurobindo Pharma Limited. It has 2 package NDCs, shown above in 10- and 11-digit form.

Aurobindo Pharma Limited, NDC labeler code 59651. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Aripiprazole?

256 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Aripiprazole NDC 59651-515 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)59651-515Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59651-0515Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
59651-515-03	59651051503	3 BLISTER PACK in 1 CARTON (59651-515-03) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACKMarketed from Feb 18, 2026
59651-515-30	59651051530	30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (59651-515-30)Marketed from Feb 18, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Aripiprazole
Generic name (nonproprietary): aripiprazole
Active ingredients: Aripiprazole — 15 mg/1
Dosage form: Tablet, Orally disintegrating
Route: Oral
Labeler: Aurobindo Pharma LimitedNDC labeler code 59651
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 216208
Marketing start: Feb 18, 2026
Listing expires: Dec 31, 2027
Identifiers: Product ID 59651-515_da73c5ab-4841-4081-8fdf-adc2ea343dcbSPL ID da73c5ab-4841-4081-8fdf-adc2ea343dcbSPL set ID 476b92f3-cf7b-4c09-ac67-6ed35e6811d5RxCUI 643019, 643022UNII 82VFR53I78
Pharmacologic class: Atypical Antipsychotic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459651051503 followed by a unit qualifier and the quantity

Package 59651-0515-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 15, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Aripiprazole orally disintegrating tablets are indicated for the treatment of: Schizophrenia [see Clinical Studies (14.1) ] Acute Treatment of Manic and Mixed Episodes associated with Bipolar I Disorder [ see Clinical Studies (14.2) ] Irritability Associated with Autistic Disorder [see Clinical Studies (14.4) ] Treatment of Tourette’s Disorder [see Clinical Studies (14.5) ] Aripiprazole is an atypical antipsychotic. The oral formulation is indicated for: Schizophrenia ( 14.1 ) Acute Treatment of Manic and Mixed Episodes associated with Bipolar I ( 14.2 ) Irritability Associated with Autistic Disorder ( 14.4 ) Treatment of Tourette's disorder ( 14.5 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 59651-515

What is NDC 59651-515?: 59651-515 is the product NDC for Aripiprazole, Aripiprazole 15 mg/1 tablet, orally disintegrating, listed with the FDA by Aurobindo Pharma Limited. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Aripiprazole.
What is the active ingredient?: Aripiprazole.
Who is the labeler?: Aurobindo Pharma Limited, NDC labeler code 59651. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Aripiprazole?: 256 other product NDCs are listed under this name. See all Aripiprazole NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Aripiprazole NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Aripiprazole	Aripiprazole 15 mg/1	TabletOral	REMEDYREPACK INC.	70518-4745	70518-4745-00
Aripiprazole	Aripiprazole 10 mg/1	TabletOral	Coupler LLC	67046-0873	67046-0873-03
Aripiprazole	Aripiprazole 15 mg/1	TabletOral	Coupler LLC	67046-2046	67046-2046-03
Aripiprazole	Aripiprazole 2 mg/1	TabletOral	Coupler LLC	67046-1052	67046-1052-03
Aripiprazole	Aripiprazole 5 mg/1	TabletOral	Unit Dose Solutions, Inc.	87441-006	87441-0006-01
Aripiprazole	Aripiprazole 20 mg/1	TabletOral	Coupler LLC	67046-1085	67046-1085-03
Aripiprazole	Aripiprazole 5 mg/1	TabletOral	Coupler LLC	67046-0885	67046-0885-03
Aripiprazole	Aripiprazole 15 mg/1	TabletOral	Coupler LLC	67046-1017	67046-1017-03
Aripiprazole	Aripiprazole 10 mg/1	TabletOral	Coupler LLC	67046-0492	67046-0492-03
Aripiprazole	Aripiprazole 10 mg/1	Tablet, Orally disintegratingOral	Aurobindo Pharma Limited	59651-514	59651-0514-0359651-0514-30

All 257 Aripiprazole NDCs

Other NDCs under ANDA 216208

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 216208
Product	Strength	Form · route	Labeler	Product NDC
Aripiprazole	Aripiprazole 10 mg/1	Tablet, Orally disintegratingOral	Aurobindo Pharma Limited	59651-514